Jefferies Starts GTX Inc. (GTXI) at Buy
Tweet Send to a FriendGet Alerts GTXI Hot Sheet
Price: $5.89 -9.1%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade GTXI Now!
Jefferies initiates coverage on GTX Inc. (NASDAQ: GTXI) with a Buy. PT $6.00.
The firm comments, "We believe GTXI shares will outperform over the next 12-18 months as the company could report Phase III data from the Ostarine's POWER-1 and -2 trials by early 2013. If successful, Ostarine could fill a significant unmet need in patients with non-small cell lung cancer that are at high risk of developing muscle wasting. Nearer-term, upside may come from Phase II data from Capesaris in prostate cancer, and should drive Phase III trials."
For more ratings news on GTX Inc. click here and for the rating history of GTX Inc. click here.
Shares of GTX Inc. closed at $4.23 yesterday, with a 52 week range of $2.27-$6.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "We believe GTXI shares will outperform over the next 12-18 months as the company could report Phase III data from the Ostarine's POWER-1 and -2 trials by early 2013. If successful, Ostarine could fill a significant unmet need in patients with non-small cell lung cancer that are at high risk of developing muscle wasting. Nearer-term, upside may come from Phase II data from Capesaris in prostate cancer, and should drive Phase III trials."
For more ratings news on GTX Inc. click here and for the rating history of GTX Inc. click here.
Shares of GTX Inc. closed at $4.23 yesterday, with a 52 week range of $2.27-$6.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Janney Capital Boosts PT on Gap (GPS) Post Q1
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
